Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
PD-1
Research
Dupixent for cancer? Researchers test med as PD-1 booster
Pairing Dupixent with PD-1 inhibitors slowed tumor growth in mouse models and stabilized disease in some patients in a small clinical trial.
Helen Floersh
Dec 7, 2023 6:00am
Gilead-Arcus' TIGIT gets high response in gastric cancer
Nov 7, 2023 9:40am
AbbVie and Calico drug boosts immunotherapy response in mice
Oct 5, 2023 11:19am
Agenus lays off 25%, sidelines programs to focus on cancer combo
Aug 23, 2023 11:04am
PD-1 R&D tapers off as new molecules capture interest: IQVIA
May 24, 2023 2:09pm
Roche acquires PD-1-focused Good Therapeutics for $250M cash
Sep 7, 2022 7:00am